drug protocol number

D6402C00012

drug sponsor

AstraZeneca

drug study

balcinrenone/dapagliflozin

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical City NG (Riyadh),King Fahad Medical City (Riyadh) ,King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase